2025-04-09 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**0) Key Figures & Initial Analysis:**

Colgate-Palmolive Co (CL) is a multinational consumer goods company specializing in oral hygiene products and personal care items.  The company's cumulative return significantly underperformed the S&P 500 (VOO) over the analyzed period.


**1) Performance Comparison with S&P 500 (VOO):**

* **CL Cumulative Return:** 27.22%
* **VOO Cumulative Return:** 56.37%
* **Return Difference:** -29.1%  (The company underperformed the S&P 500 by 29.1 percentage points.)
* **Relative Divergence:** 49.4% (This means CL's underperformance relative to VOO is in the lower 49.4th percentile of its historical range. This is a relative measure not an absolute statement of underperformance.)

The provided alpha and beta analysis shows varying performance relative to the market (S&P 500) over different time periods.  Alpha values, generally positive, suggest periods of outperformance, while beta shows varying levels of market sensitivity (with higher numbers representing greater sensitivity).  Note that past performance does not guarantee future results.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.8% | -16.0% | 0.1 | 51.6 |
| 2016-2018  | -11.0% | 65.2% | -29.0% | 0.1 | 41.7 |
| 2017-2019  | 7.0% | 65.2% | -22.0% | 0.2 | 49.4 |
| 2018-2020  | 18.0% | 65.2% | -8.0% | 0.7 | 62.9 |
| 2019-2021  | 30.0% | 58.6% | -25.0% | 1.0 | 64.2 |
| 2020-2022  | 8.0% | 68.9% | 1.0% | 1.0 | 60.7 |
| 2021-2023  | 5.0% | 68.9% | -12.0% | 0.9 | 63.0 |
| 2022-2024  | 12.0% | 68.9% | -5.0% | 0.8 | 73.4 |
| 2023-2025  | 14.0% | 62.4% | 9.0% | 0.4 | 72.2 |



**2) Recent Price Movement:**

* **Closing Price:** $88.86
* **Last Market Price:** $88.94 (down $0.28 from the previous close)
* **5-Day Moving Average:** $92.79
* **20-Day Moving Average:** $91.63
* **60-Day Moving Average:** $89.84

The price is currently below all three moving averages, suggesting a potential downward trend in the short to medium term.  The recent slight decrease ($0.28) is not significant enough to classify as a sharp drop.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4883 (High Risk)  This suggests a high level of market volatility.
* **RSI:** 48.25 (Slightly below neutral; neither overbought nor oversold)
* **PPO:** -0.1999 (Negative, indicating bearish momentum)
* **20-Day Relative Divergence Change:** +13.3% (Short-term upward momentum)
* **Expected Return:** -38.4% (This suggests significant underperformance relative to the S&P 500 over the long term (2+ years),  a significant negative number)


**4) Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2024-10-25 | $0.9 | $5.03 Billion |
| 2024-07-26 | $0.89| $5.06 Billion |
| 2024-04-26 | $0.83| $5.07 Billion |
| 2023-10-27 | $0.86| $4.92 Billion |
| 2024-10-25 | $0.86| $4.92 Billion | *(Duplicate entry, likely an error)*


Revenue is relatively stable, showing minor fluctuations.  EPS shows a slight upward trend overall. The duplicate entry needs clarification.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B | 60.30% |
| 2024-09-30 | $5.03B | 61.08% |
| 2024-06-30 | $5.06B | 60.62% |
| 2024-03-31 | $5.07B | 60.00% |
| 2023-12-31 | $4.95B | 59.60% |

Revenue remains relatively consistent. Profit margins are consistently high and stable around 60%.


**Capital and Profitability:**

| Quarter | Equity | ROE       |
|---------|---------|------------|
| 2024-12-31 | $0.21B | 348.58%   |
| 2024-09-30 | $0.43B | 169.43%   |
| 2024-06-30 | $0.12B | 594.31%   |
| 2024-03-31 | $0.23B | 296.96%   |
| 2023-12-31 | $0.61B | 117.90%   |

Equity and ROE show significant volatility.  The extremely high ROE figures in some quarters need further investigation to understand the underlying reasons. This might indicate accounting practices which require further analysis.


**6) Overall Analysis:**

Colgate-Palmolive (CL) shows mixed signals. While revenue and profit margins remain stable and strong, the stock's underperformance relative to the S&P 500 is substantial.  Technical indicators suggest a bearish short-term trend, though the RSI is not strongly oversold.  The high volatility in equity and ROE from the provided financial information raises concerns and requires further investigation into financial reporting practices before a conclusive statement can be reached.  The significantly negative expected return in conjunction with the underperformance relative to the S&P 500 suggests caution before a long-term investment.  Further due diligence, including a review of the company's specific business conditions and financial reports, is highly recommended before making any investment decisions.
